APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-Clinical CRO Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Non-Clinical CRO Services Market Outlook and Growth Opportunities 2026

1 May 2026181 pages

Choose your research edition.

Industry ResearchNon-Clinical CRO Services Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-Clinical CRO Services Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Non-Clinical CRO Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-Clinical CRO Services Market Outlook and Growth Opportunities 2026181 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-Clinical CRO Services Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Non-Clinical CRO Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Non-Clinical CRO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non-Clinical CRO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-Clinical CRO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Non-Clinical CRO Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Non-Clinical CRO Services market include CMIC Group, Shanghai Innostar Biotech, ApconiX, Charles River Laboratories, ERBC Group, STILLMEADOW and ICON, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Non-Clinical CRO Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non-Clinical CRO Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non-Clinical CRO Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Non-Clinical CRO Services market.

Non-Clinical CRO Services Segment by Company

CMIC Group

Shanghai Innostar Biotech

ApconiX

Charles River Laboratories

ERBC Group

STILLMEADOW

ICON

Non-Clinical CRO Services Segment by Type

Safety Pharmacology Testing

Administration Toxicity Test

Reproductive Toxicity Test

Genotoxicity Test

Immunogenicity Studies

Carcinogenicity Test

Other

Non-Clinical CRO Services Segment by Application

Pharmaceutical Center

Institute

Hospital

Non-Clinical CRO Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Non-Clinical CRO Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Non-Clinical CRO Services key companies, revenue, market share, and recent developments.

3. To split the Non-Clinical CRO Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Non-Clinical CRO Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Non-Clinical CRO Services significant trends, drivers, influence factors in global and regions.

6. To analyze Non-Clinical CRO Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Clinical CRO Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-Clinical CRO Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Clinical CRO Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Non-Clinical CRO Services industry.

Chapter 3: Detailed analysis of Non-Clinical CRO Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Non-Clinical CRO Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Non-Clinical CRO Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Non-Clinical CRO Services Industry Trends Table 2. Non-Clinical CRO Services Industry Drivers Table 3. Non-Clinical CRO Services Industry Opportunities and Challenges Table 4. Non-Clinical CRO Services Industry Restraints Table 5. Global Non-Clinical CRO Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Non-Clinical CRO Services Revenue Share by Company (2021-2026) Table 7. Global Non-Clinical CRO Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Non-Clinical CRO Services Key Company Manufacturing Base & Headquarters Table 9. Global Non-Clinical CRO Services Company, Product Type & Application Table 10. Global Non-Clinical CRO Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Non-Clinical CRO Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Safety Pharmacology Testing Table 15. Significant Companies of Administration Toxicity Test Table 16. Significant Companies of Reproductive Toxicity Test Table 17. Significant Companies of Genotoxicity Test Table 18. Significant Companies of Immunogenicity Studies Table 19. Significant Companies of Carcinogenicity Test Table 20. Significant Companies of Other Table 21. Global Non-Clinical CRO Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 22. Global Non-Clinical CRO Services Sales Value by Type (2021-2026) & (US$ Million) Table 23. Global Non-Clinical CRO Services Sales Value by Type (2027-2032) & (US$ Million) Table 24. Global Non-Clinical CRO Services Sales Value Share by Type (2021-2026) Table 25. Global Non-Clinical CRO Services Sales Value Share by Type (2027-2032) Table 26. Significant Companies of Pharmaceutical Center Table 27. Significant Companies of Institute Table 28. Significant Companies of Hospital Table 29. Global Non-Clinical CRO Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Non-Clinical CRO Services Sales Value by Application (2021-2026) & (US$ Million) Table 31. Global Non-Clinical CRO Services Sales Value by Application (2027-2032) & (US$ Million) Table 32. Global Non-Clinical CRO Services Sales Value Share by Application (2021-2026) Table 33. Global Non-Clinical CRO Services Sales Value Share by Application (2027-2032) Table 34. Global Non-Clinical CRO Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Non-Clinical CRO Services Sales Value by Region (2021-2026) & (US$ Million) Table 36. Global Non-Clinical CRO Services Sales Value Share by Region (2021-2026) Table 37. Global Non-Clinical CRO Services Sales Value by Region (2027-2032) & (US$ Million) Table 38. Global Non-Clinical CRO Services Sales Value Share by Region (2027-2032) Table 39. Global Non-Clinical CRO Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Non-Clinical CRO Services Sales Value by Country (2021-2026) & (US$ Million) Table 41. Global Non-Clinical CRO Services Sales Value Market Share by Country (2021-2026) Table 42. Global Non-Clinical CRO Services Sales Value by Country (2027-2032) & (US$ Million) Table 43. Global Non-Clinical CRO Services Sales Value Market Share by Country (2027-2032) Table 44. CMIC Group Company Information Table 45. CMIC Group Business Overview Table 46. CMIC Group Non-Clinical CRO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. CMIC Group Non-Clinical CRO Services Product Portfolio Table 48. CMIC Group Recent Development Table 49. Shanghai Innostar Biotech Company Information Table 50. Shanghai Innostar Biotech Business Overview Table 51. Shanghai Innostar Biotech Non-Clinical CRO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Shanghai Innostar Biotech Non-Clinical CRO Services Product Portfolio Table 53. Shanghai Innostar Biotech Recent Development Table 54. ApconiX Company Information Table 55. ApconiX Business Overview Table 56. ApconiX Non-Clinical CRO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. ApconiX Non-Clinical CRO Services Product Portfolio Table 58. ApconiX Recent Development Table 59. Charles River Laboratories Company Information Table 60. Charles River Laboratories Business Overview Table 61. Charles River Laboratories Non-Clinical CRO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Charles River Laboratories Non-Clinical CRO Services Product Portfolio Table 63. Charles River Laboratories Recent Development Table 64. ERBC Group Company Information Table 65. ERBC Group Business Overview Table 66. ERBC Group Non-Clinical CRO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. ERBC Group Non-Clinical CRO Services Product Portfolio Table 68. ERBC Group Recent Development Table 69. STILLMEADOW Company Information Table 70. STILLMEADOW Business Overview Table 71. STILLMEADOW Non-Clinical CRO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. STILLMEADOW Non-Clinical CRO Services Product Portfolio Table 73. STILLMEADOW Recent Development Table 74. ICON Company Information Table 75. ICON Business Overview Table 76. ICON Non-Clinical CRO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. ICON Non-Clinical CRO Services Product Portfolio Table 78. ICON Recent Development Table 79. Research Programs/Design for This Report Table 80. Authors List of This Report Table 81. Secondary Sources Table 82. Primary Sources List of Figures Figure 1. Non-Clinical CRO Services Product Image Figure 2. Global Non-Clinical CRO Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-Clinical CRO Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Non-Clinical CRO Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Safety Pharmacology Testing Image Figure 8. Administration Toxicity Test Image Figure 9. Reproductive Toxicity Test Image Figure 10. Genotoxicity Test Image Figure 11. Immunogenicity Studies Image Figure 12. Carcinogenicity Test Image Figure 13. Other Image Figure 14. Global Non-Clinical CRO Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Non-Clinical CRO Services Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Non-Clinical CRO Services Sales Value Share by Type (2021-2032) Figure 17. Pharmaceutical Center Image Figure 18. Institute Image Figure 19. Hospital Image Figure 20. Global Non-Clinical CRO Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Non-Clinical CRO Services Sales Value Share 2021 VS 2025 VS 2032 Figure 22. Global Non-Clinical CRO Services Sales Value Share by Application (2021-2032) Figure 23. Global Non-Clinical CRO Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 24. Global Non-Clinical CRO Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 25. North America Non-Clinical CRO Services Sales Value (2021-2032) & (US$ Million) Figure 26. North America Non-Clinical CRO Services Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Europe Non-Clinical CRO Services Sales Value (2021-2032) & (US$ Million) Figure 28. Europe Non-Clinical CRO Services Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Asia-Pacific Non-Clinical CRO Services Sales Value (2021-2032) & (US$ Million) Figure 30. Asia-Pacific Non-Clinical CRO Services Sales Value Share by Country (%), 2025 VS 2032 Figure 31. South America Non-Clinical CRO Services Sales Value (2021-2032) & (US$ Million) Figure 32. South America Non-Clinical CRO Services Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Middle East & Africa Non-Clinical CRO Services Sales Value (2021-2032) & (US$ Million) Figure 34. Middle East & Africa Non-Clinical CRO Services Sales Value Share by Country (%), 2025 VS 2032 Figure 35. USA Non-Clinical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. USA Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. USA Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Canada Non-Clinical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Canada Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Canada Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Mexico Non-Clinical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Mexico Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Mexico Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Germany Non-Clinical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Germany Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Germany Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. France Non-Clinical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. France Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. France Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. U.K. Non-Clinical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. U.K. Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. U.K. Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Italy Non-Clinical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Italy Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Italy Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Spain Non-Clinical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Spain Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Spain Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Russia Non-Clinical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Russia Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Russia Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Netherlands Non-Clinical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Netherlands Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Netherlands Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Nordic Countries Non-Clinical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Nordic Countries Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Nordic Countries Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. China Non-Clinical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. China Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. China Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Japan Non-Clinical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Japan Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Japan Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. South Korea Non-Clinical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. South Korea Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. South Korea Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. India Non-Clinical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. India Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. India Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Australia Non-Clinical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Australia Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Australia Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Southeast Asia Non-Clinical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Southeast Asia Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Southeast Asia Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Brazil Non-Clinical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Brazil Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Brazil Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Argentina Non-Clinical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Argentina Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Argentina Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Chile Non-Clinical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Chile Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Chile Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Colombia Non-Clinical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Colombia Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Colombia Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Peru Non-Clinical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Peru Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Peru Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Non-Clinical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Saudi Arabia Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Saudi Arabia Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Israel Non-Clinical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Israel Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Israel Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. UAE Non-Clinical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. UAE Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. UAE Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Turkey Non-Clinical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Turkey Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Turkey Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Iran Non-Clinical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Iran Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Iran Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Egypt Non-Clinical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Egypt Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Egypt Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Years Considered Figure 120. Research Process Figure 121. Key Executives Interviewed

Scope & coverage.

Types
  • Safety Pharmacology Testing
  • Administration Toxicity Test
  • Reproductive Toxicity Test
  • Genotoxicity Test
  • Immunogenicity Studies
  • Carcinogenicity Test
  • Other
Applications
  • Pharmaceutical Center
  • Institute
  • Hospital
Companies covered
  • CMIC Group
  • Shanghai Innostar Biotech
  • ApconiX
  • Charles River Laboratories
  • ERBC Group
  • STILLMEADOW
  • ICON

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Non-Clinical CRO Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Non-Clinical CRO Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Non-Clinical CRO Services Market Dynamics
  1. 2.1 Non-Clinical CRO Services Industry Trends
  2. 2.2 Non-Clinical CRO Services Industry Drivers
  3. 2.3 Non-Clinical CRO Services Industry Opportunities and Challenges
  4. 2.4 Non-Clinical CRO Services Industry Restraints
3 Non-Clinical CRO Services Market by Company
  1. 3.1 Global Non-Clinical CRO Services Company Revenue Ranking in 2025
  2. 3.2 Global Non-Clinical CRO Services Revenue by Company (2021-2026)
  3. 3.3 Global Non-Clinical CRO Services Company Ranking (2024-2026)
  4. 3.4 Global Non-Clinical CRO Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Non-Clinical CRO Services Company Product Type and Application
  6. 3.6 Global Non-Clinical CRO Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Non-Clinical CRO Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Non-Clinical CRO Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Non-Clinical CRO Services Market by Type
  1. 4.1 Non-Clinical CRO Services Type Introduction
  2. 4.1.1 Safety Pharmacology Testing
  3. 4.1.2 Administration Toxicity Test
  4. 4.1.3 Reproductive Toxicity Test
  5. 4.1.4 Genotoxicity Test
  6. 4.1.5 Immunogenicity Studies
  7. 4.1.6 Carcinogenicity Test
  8. 4.1.7 Other
  9. 4.2 Global Non-Clinical CRO Services Sales Value by Type
  10. 4.2.1 Global Non-Clinical CRO Services Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Non-Clinical CRO Services Sales Value by Type (2021-2032)
  12. 4.2.3 Global Non-Clinical CRO Services Sales Value Share by Type (2021-2032)
5 Non-Clinical CRO Services Market by Application
  1. 5.1 Non-Clinical CRO Services Application Introduction
  2. 5.1.1 Pharmaceutical Center
  3. 5.1.2 Institute
  4. 5.1.3 Hospital
  5. 5.2 Global Non-Clinical CRO Services Sales Value by Application
  6. 5.2.1 Global Non-Clinical CRO Services Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Non-Clinical CRO Services Sales Value by Application (2021-2032)
  8. 5.2.3 Global Non-Clinical CRO Services Sales Value Share by Application (2021-2032)
6 Non-Clinical CRO Services Regional Value Analysis
  1. 6.1 Global Non-Clinical CRO Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non-Clinical CRO Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Non-Clinical CRO Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Non-Clinical CRO Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Non-Clinical CRO Services Sales Value (2021-2032)
  7. 6.3.2 North America Non-Clinical CRO Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Non-Clinical CRO Services Sales Value (2021-2032)
  10. 6.4.2 Europe Non-Clinical CRO Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Non-Clinical CRO Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Non-Clinical CRO Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Non-Clinical CRO Services Sales Value (2021-2032)
  16. 6.6.2 South America Non-Clinical CRO Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Non-Clinical CRO Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Non-Clinical CRO Services Sales Value Share by Country, 2025 VS 2032
7 Non-Clinical CRO Services Country-level Value Analysis
  1. 7.1 Global Non-Clinical CRO Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Non-Clinical CRO Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Non-Clinical CRO Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Non-Clinical CRO Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Non-Clinical CRO Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Non-Clinical CRO Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Non-Clinical CRO Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Non-Clinical CRO Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Non-Clinical CRO Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Non-Clinical CRO Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Non-Clinical CRO Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Non-Clinical CRO Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Non-Clinical CRO Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Non-Clinical CRO Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Non-Clinical CRO Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Non-Clinical CRO Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Non-Clinical CRO Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Non-Clinical CRO Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Non-Clinical CRO Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Non-Clinical CRO Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Non-Clinical CRO Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Non-Clinical CRO Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Non-Clinical CRO Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Non-Clinical CRO Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Non-Clinical CRO Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Non-Clinical CRO Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Non-Clinical CRO Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Non-Clinical CRO Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Non-Clinical CRO Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Non-Clinical CRO Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Non-Clinical CRO Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Non-Clinical CRO Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Non-Clinical CRO Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Non-Clinical CRO Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CMIC Group
  2. 8.1.1 CMIC Group Company Information
  3. 8.1.2 CMIC Group Business Overview
  4. 8.1.3 CMIC Group Non-Clinical CRO Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CMIC Group Non-Clinical CRO Services Product Portfolio
  6. 8.1.5 CMIC Group Recent Developments
  7. 8.2 Shanghai Innostar Biotech
  8. 8.2.1 Shanghai Innostar Biotech Company Information
  9. 8.2.2 Shanghai Innostar Biotech Business Overview
  10. 8.2.3 Shanghai Innostar Biotech Non-Clinical CRO Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Shanghai Innostar Biotech Non-Clinical CRO Services Product Portfolio
  12. 8.2.5 Shanghai Innostar Biotech Recent Developments
  13. 8.3 ApconiX
  14. 8.3.1 ApconiX Company Information
  15. 8.3.2 ApconiX Business Overview
  16. 8.3.3 ApconiX Non-Clinical CRO Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 ApconiX Non-Clinical CRO Services Product Portfolio
  18. 8.3.5 ApconiX Recent Developments
  19. 8.4 Charles River Laboratories
  20. 8.4.1 Charles River Laboratories Company Information
  21. 8.4.2 Charles River Laboratories Business Overview
  22. 8.4.3 Charles River Laboratories Non-Clinical CRO Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Charles River Laboratories Non-Clinical CRO Services Product Portfolio
  24. 8.4.5 Charles River Laboratories Recent Developments
  25. 8.5 ERBC Group
  26. 8.5.1 ERBC Group Company Information
  27. 8.5.2 ERBC Group Business Overview
  28. 8.5.3 ERBC Group Non-Clinical CRO Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 ERBC Group Non-Clinical CRO Services Product Portfolio
  30. 8.5.5 ERBC Group Recent Developments
  31. 8.6 STILLMEADOW
  32. 8.6.1 STILLMEADOW Company Information
  33. 8.6.2 STILLMEADOW Business Overview
  34. 8.6.3 STILLMEADOW Non-Clinical CRO Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 STILLMEADOW Non-Clinical CRO Services Product Portfolio
  36. 8.6.5 STILLMEADOW Recent Developments
  37. 8.7 ICON
  38. 8.7.1 ICON Company Information
  39. 8.7.2 ICON Business Overview
  40. 8.7.3 ICON Non-Clinical CRO Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 ICON Non-Clinical CRO Services Product Portfolio
  42. 8.7.5 ICON Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst